Project Grant R01AI060689

Summary Louisiana State University will develop novel mucosal vaccines to protect poultry from Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.3.4.4b under a $1.92 million Cooperative Agreement awarded by the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025). The project, which commenced February 2, 2026, and concludes February 1, 2029, will deliver three primary...

Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida $422,125 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 23, 2025, for a project extending through June 30, 2027. This Project Grant funds development of a novel vaccine delivery platform using Salmonella-based antigen delivery to combat Francisella tularensis infection. The research will construct Protective Immunity Enhanced Salmonella...

Federal Project Grant Summary Solaris Vaccines, Inc. received a $269,874 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025 through July 31, 2027. The award funds development and evaluation of SOLAVAX-TB, a whole-cell inactivated Mycobacterium tuberculosis vaccine designed to address critical gaps in existing tuberculosis prevention. The vaccine uses a novel...

Summary The Animal and Plant Health Inspection Service (APHIS) awarded the Regents of the University of Minnesota a Cooperative Agreement valued at $810,568 under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), effective February 2, 2026, through February 1, 2029. The primary deliverable is development and efficacy assessment of a novel lactococcal-phage vaccine designed to protect poultry from highly pathogenic avian influenza (HPAI) H5N1 Clade 2.3.4.4b. The...

Federal Cooperative Agreement Summary The Research Foundation for the State University of New York at Binghamton received a $2.49 million Cooperative Agreement from the Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), awarded February 2, 2026, with completion targeted for February 1, 2029. The award funds development of a feedable multivalent vaccine to protect poultry from highly pathogenic avian...

Federal Cooperative Agreement Award Summary Centivax, Inc. received a $1.99M cooperative agreement from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), awarded February 2, 2026, with completion targeted for February 1, 2028. Centivax will advance CENTI-POULT-H5, a broadly protective vaccine designed to protect poultry from highly pathogenic avian influenza (HPAI)....

Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Viva Viral Vaccines, Inc. a Project Grant totaling $299,968 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period of September 25, 2025 through August 31, 2026. The award supports development of a broad-spectrum, multivalent vaccine platform targeting influenza neuraminidase (NA) protein to provide enhanced protection against seasonal and pandemic...

Summary of Federal Cooperative Agreement Award Kansas State University received a $2.0 million Cooperative Agreement from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025), awarded February 2, 2026, with completion scheduled for February 1, 2029. The project addresses the critical threat posed by Highly Pathogenic Avian Influenza (HPAI) H5N1 to U.S. poultry production and...

This Project Grant from the Department of Agriculture's National Institute of Food and Agriculture, under the Small Business Innovation Research (SBIR) Program/Small Business Technology Transfer (STTR) Program (CFDA 10.212), provides $135,484 to Larad Inc. to develop an enzyme-linked immunosorbent assay (ELISA) kit. The kit aims to differentiate between Marek's disease virus infected and herpesvirus of turkeys vectored vaccinated poultry flocks. Larad will purify individual glycoprotein antigens...

The Defense Health Agency awarded Flugen Inc. a $6,237,445 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to optimize downstream recovery and stabilization of the drug substance for their intranasal influenza vaccine. The three-year grant also supports research on concurrent administration of Flugen's H3N2 M2SR monovalent influenza vaccine with inactivated flu vaccines in older adult populations. This award builds on Flugen's previous federal grants...